UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
February 3, 2000
Commission File Number: 0-18929
-----------------------------------
SEMCOLABS, INC.
(Exact name of registrant as specified in its charter)
Nevada 13-3432594
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
11300 W. Olympic Blvd., Suite 800, Los Angeles, California 90064
(Address of principal executive offices)
(888) 355-8805
(Issuer's telephone number, including area code)
N/A
(Former name, former address and former fiscal year,
if changed since last report)
<PAGE>
Item 1. Changes in Control of Registrant
The corporation, commencing on February 3, 2000, elected to
rescind the Corporate Combination Agreement with SemcoLABS, Inc.,
a Florida corporation. The rescission was based upon a failure
of consideration to have been timely delivered by the Florida
corporation.
Gary Rosen resigned as an officer and director of the
corporation. The effect of the rescission will be cancellation
of approximately 18,000,000 shares of restricted common stock
that had been issued in reliance upon the combination. The
Company will continue to work within the core business of
sanitary compliance for retail establishments and will change its
name to reflect the modified corporate structure.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly authorized.
Date: February 29, 2000 /s/ Thomas E. Hanson
Thomas E. Hanson, President
